Seite aktualisiert: 15 Mar 2026
Boehringer Ingelheim
·Rank 16
Boehringer Ingelheim is a pharmaceutical and biotechnology company operating carbon accounting and lifecycle assessment consulting services with a validated Science-Based Target aligned to 1.5°C through the SBTi. The company specializes in sectors including pharmaceuticals, biotechnology, and life sciences.
Company Overview
Active in carbon accounting, life cycle assessment and sustainability consulting and science-based emissions reduction targets within the German industrial sector.
Market Context
Germany's carbon accounting sector is driven by EU CSRD requirements affecting an estimated 15,000 German companies.
Unternehmensdetails
| Company Name | Boehringer Ingelheim |
| Country | 🇩🇪 Germany |
| Sector | Carbon Accounting & Industrial Decarbonization |
Klassifizierung
Specializations: Pharmaceuticals, Biotechnology and Life Sciences
Certifications: SBTi Target Validated · Target: 1.5°C
Über diesen Eintrag
Boehringer Ingelheim is included in this directory because it is classified under carbon accounting based on business activity.
Information on this page is compiled from public business registers and industry databases. If you represent this company and would like to update or expand this listing, use the "Claim Listing" option.
Ähnliche Lieferanten